Insight Molecular Diagnostics Inc. Proceeds from Issuance of Private Placement
Insight Molecular Diagnostics Inc. (IMDX) reported Proceeds from Issuance of Private Placement of $31.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2022-05-12
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for the quarter ending 2022-03-31 was $31.00K, a 99.54% decline year-over-year.
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for the quarter ending 2021-12-31 was $0.00.
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for the quarter ending 2021-09-30 was $6.24M.
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for the quarter ending 2021-06-30 was -$271.00K.
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for fiscal 2021 was $12.72M, a 416.82% increase from fiscal 2020.
- Insight Molecular Diagnostics Inc. proceeds from issuance of private placement for fiscal 2020 was $2.46M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2022-03-31 | $31.00K 10-Q · filed 2022-05-12 | $31.00K derived: sum of 2 quarters · filed 2022-05-12 | $6.27M derived: sum of 3 quarters · filed 2022-05-12 | $6.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $6.24M derived: sum of 2 quarters · filed 2022-03-11 | $5.97M derived: sum of 3 quarters · filed 2022-03-11 | $12.72M 10-K · filed 2022-03-11 |
| 2021-09-30 | $6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $5.97M derived: sum of 2 quarters · filed 2021-11-09 | $12.72M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$271.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $6.48M 10-Q · filed 2021-08-11 | ||
| 2021-03-31 | $6.75M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $2.46M 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |